Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy

Published:2017-12 Issue:1 Volume:36 Page:
ISSN:1944-446X
Container-title:Chinese Journal of Cancer
language:en
Short-container-title:Chin J Cancer

Author:

Ma Li,Qiu Bo,Zhang Jun,Li Qi-Wen,Wang Bin,Zhang Xu-Hui,Qiang Meng-Yun,Chen Zhao-Lin,Guo Su-Ping,Liu Hui

Funder

Science and Technology Planning Project of Guangdong Province, China

The Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; and National Nature Science Fund

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1186/s40880-017-0261-0.pdf

Reference35 articles.

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.

2. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007;2(8):706–14.

3. Yang HX. Long-term survival of early-stage non-small cell lung cancer patients who underwent robotic procedure: a propensity score-matched study. Chin J Cancer. 2016;35(1):66.

4. Endo C, Sakurada A, Notsuda H, Noda M, Hoshikawa Y, Okada Y, et al. Results of long-term follow-up of patients with completely resected non-small cell lung cancer. Ann Thorac Surg. 2012;93(4):1061–8.

5. Kelsey CR, Marks LB, Hollis D, Hubbs JL, Ready NE, D’Amico TA, et al. Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients. Cancer. 2009;115(22):5218–27.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of cemiplimab plus chemotherapy versus chemotherapy for the treatment of advanced non-small cell lung cancer;Frontiers in Oncology;2023-04-26

2. Image-Guided Percutaneous and Transarterial Therapies for Primary and Metastatic Lung Cancer;Technology in Cancer Research & Treatment;2023-01

3. The Value of Circulating Tumor Cells and Tumor Markers Detection in Lung Cancer Diagnosis;Technology in Cancer Research & Treatment;2023-01

4. Is the neutrophil-to-lymphocyte ratio a prognostic factor in non-small cell lung cancer patients who receive adjuvant chemotherapy?;Seminars in Oncology;2022-12

5. Survival benefit of resection surgery for lung adenocarcinoma with bone metastases and a post-operative prognosis nomogram establishment and validation;Journal of Thoracic Disease;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3